Changes
Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.
<br>
{|border="0" cellspacing="0" cellpadding="4" width="80%" align="center"
|
|
|
|
|-
|
|bgcolor = "#376091" colspan = "2"|<font color="#FFFFFF">'''Conmed'''</font>
|
|-
|
|bgcolor = "#C5D9F1"|'''Brief Description'''
|bgcolor = "#C5D9F1"|The medical technology company develops and manufactures a wide range of electronic instruments such as electrosurgical systems, powered surgical instruments, and endoscopic devices. Arthroscopic (joint surgery) products represent the company's largest segment and include reconstruction tools, scopes, implants, and fluid management systems. CONMED also manufactures patient monitoring products and handheld medical accessories such as scissors, sutures, and staplers. Brands include Linvatec and Hall Surgical. The company sells its products in more than 100 countries through its direct sales force and independent distributors.
|
|-
|
|rowspan = "3"|'''Revenues'''
|2008: 742.18 million USD
|
|-
|
|2009: 694.74 million USD
|
|-
|
|2010: 713.72 million USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Net profit (2010)'''
|bgcolor = "#C5D9F1"| 30.35 million USD
|
|-
|
|rowspan = "3"|'''R&D expenses'''
|2008: 33.1 million USD
|
|-
|
|2009: 31.8 million USD
|
|-
|
|2010: 29.6 million USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Number of employees'''
|bgcolor = "#C5D9F1"|3,300
|
|-
|
|'''Year Established'''
|1970
|
|-
|
|bgcolor = "#C5D9F1"|'''Headquarters'''
|bgcolor = "#C5D9F1"|525 French Rd. Utica, NY 13502,United States
|
|-
|
|'''Key People'''
|Joseph Corasanti (CEO)<br>Eugene Corasanti (Chairman)
|
|-
|
|bgcolor = "#C5D9F1"|'''Segmental revenue breakdown (2010)'''
|bgcolor = "#C5D9F1"|Linvatec: 60%<br>Electrosurgery: 14%<br>Endosurgery: 10%<br>Patient Care: 9%<br>Endoscopic Technologies: 7%
|
|-
|
|'''Geographical revenue breakdown (2010)'''
|US: 52%<br>Canada: 9%<br>Rest of world: 39%
|
|-
|}<br clear="all">
<br>
{|border="0" cellspacing="0" cellpadding="4" width="80%" align="center"
|
|
|
|
|-
|
|bgcolor = "#376091" colspan = "2"|<font color="#FFFFFF">'''Conmed'''</font>
|
|-
|
|bgcolor = "#C5D9F1"|'''Brief Description'''
|bgcolor = "#C5D9F1"|The medical technology company develops and manufactures a wide range of electronic instruments such as electrosurgical systems, powered surgical instruments, and endoscopic devices. Arthroscopic (joint surgery) products represent the company's largest segment and include reconstruction tools, scopes, implants, and fluid management systems. CONMED also manufactures patient monitoring products and handheld medical accessories such as scissors, sutures, and staplers. Brands include Linvatec and Hall Surgical. The company sells its products in more than 100 countries through its direct sales force and independent distributors.
|
|-
|
|rowspan = "3"|'''Revenues'''
|2008: 742.18 million USD
|
|-
|
|2009: 694.74 million USD
|
|-
|
|2010: 713.72 million USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Net profit (2010)'''
|bgcolor = "#C5D9F1"| 30.35 million USD
|
|-
|
|rowspan = "3"|'''R&D expenses'''
|2008: 33.1 million USD
|
|-
|
|2009: 31.8 million USD
|
|-
|
|2010: 29.6 million USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Number of employees'''
|bgcolor = "#C5D9F1"|3,300
|
|-
|
|'''Year Established'''
|1970
|
|-
|
|bgcolor = "#C5D9F1"|'''Headquarters'''
|bgcolor = "#C5D9F1"|525 French Rd. Utica, NY 13502,United States
|
|-
|
|'''Key People'''
|Joseph Corasanti (CEO)<br>Eugene Corasanti (Chairman)
|
|-
|
|bgcolor = "#C5D9F1"|'''Segmental revenue breakdown (2010)'''
|bgcolor = "#C5D9F1"|Linvatec: 60%<br>Electrosurgery: 14%<br>Endosurgery: 10%<br>Patient Care: 9%<br>Endoscopic Technologies: 7%
|
|-
|
|'''Geographical revenue breakdown (2010)'''
|US: 52%<br>Canada: 9%<br>Rest of world: 39%
|
|-
|}<br clear="all">
